Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/01/2003EP1348715A2 CD19xCD3 specific polypeptides and uses thereof
10/01/2003EP1348712A1 L-nucleic acid derivatives and processes for the synthesis thereof
10/01/2003EP1348709A2 Thiazolo (4,5-D) pyrimidine compounds
10/01/2003EP1348707A1 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/01/2003EP1348706A1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
10/01/2003EP1348704A1 Indole derivatives as 5-HT2C antagonists, process for their preparation and pharmaceutical compositions containing them
10/01/2003EP1348703A1 Polymorph forms of fasidotril, their processes of preparation and pharmaceutical compositions containing them
10/01/2003EP1348701A1 (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
10/01/2003EP1348698A1 Substituted carboxylic acid derivatives
10/01/2003EP1348466A2 Method for treating pain with adenosine-tetraphosphates
10/01/2003EP1348443A1 Combination drugs
10/01/2003EP1348442A1 Antiobestic agents and health foods
10/01/2003EP1348438A1 Compositions comprising d-chiro-inositol for treating hyperlipidemia
10/01/2003EP1348437A2 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
10/01/2003EP1348436A1 Meloxicam suppositories
10/01/2003EP1348434A1 Use of pyridyl amides as inhibitors of angiogenesis
10/01/2003EP1348433A1 Thiazol-2-yl-imine compounds as PDE-7 inhibitors
10/01/2003EP1348432A1 Cyclodextrin-containing pharmaceutical preparation
10/01/2003EP1348431A1 Process for producing nanoparticles of paclitaxel and albumin
10/01/2003EP1348430A1 Improved paclitaxel-based antitumor formulation
10/01/2003EP1348429A2 Melt-extruded orally administrable opioid formulations
10/01/2003EP1348428A1 Powdery preparations and proecss for producing the same
10/01/2003EP1348427A1 Ophthalmic compositions containing galactomannan polymers and borate
10/01/2003EP1348418A1 Cosmetical or dermatological composition containing a tetrahydrocurcumin derivative and an oil bearing an amide group
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347987A1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
10/01/2003EP1347986A2 Crystalline glucosamine sulphate metal salts and processes for preparing the same
10/01/2003EP1347985A2 Biotin derivatives, methods for making same and uses thereof as vectors
10/01/2003EP1347984A2 A process for the preparation of taxan derivatives
10/01/2003EP1347982A2 Spiro isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
10/01/2003EP1347981A1 Condensed purine derivatives as a 1? adenosine receptor antagonists
10/01/2003EP1347980A1 Compounds specific to adenosine-a1,-a2a, and- a3-receptor and uses thereof
10/01/2003EP1347979A1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
10/01/2003EP1347978A1 Novel substituted imidazotriazinones as pde ii-inhibitors
10/01/2003EP1347976A2 Tricyclic purine compounds and their analogs as inhibiotrs of cytokine signalling
10/01/2003EP1347975A1 Novel purine derivatives, preparation method and use as medicines
10/01/2003EP1347974A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
10/01/2003EP1347973A1 Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
10/01/2003EP1347972A1 Pyrazolo 3,4-c]pyridines as gsk-3 inhibitors
10/01/2003EP1347971A1 Thiazolyl inhibitors of tec family tyrosine kinases
10/01/2003EP1347968A1 Lfa-1 antagonist compounds
10/01/2003EP1347967A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/01/2003EP1347965A1 New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
10/01/2003EP1347963A2 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors
10/01/2003EP1347959A1 Indole derivatives as ligands of thyroid receptors
10/01/2003EP1347958A1 Process for preparing distamycin derivatives
10/01/2003EP1347955A1 New mandelic acid derivatives and their use as throbin inhibitors
10/01/2003EP1347805A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body
10/01/2003EP1347787A1 Procedure and composition of treatment and/or care of the eye
10/01/2003EP1347782A1 Compositions comprising cyclodextrins and no-releasing drugs
10/01/2003EP1347780A1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides
10/01/2003EP1347779A2 Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage
10/01/2003EP1347778A1 Behavior chemotherapy
10/01/2003EP1347776A2 Anti-inflammatory use of polycationic compounds
10/01/2003EP1347773A2 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
10/01/2003EP1347771A2 Methods of using imxp-888 and imxp-888 antagonists
10/01/2003EP1347766A2 Composition for the treatment of osteoarthritis
10/01/2003EP1347765A2 Dermatological formulations
10/01/2003EP1347764A2 Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism
10/01/2003EP1347763A1 Neuroactive steroid derivatives and methods of use
10/01/2003EP1347762A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
10/01/2003EP1347761A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/01/2003EP1347760A2 Nmda receptor agonist pharmaceutical compositions
10/01/2003EP1347759A1 Antibacterial compounds
10/01/2003EP1347758A1 Azole compounds as anti-fungals agents
10/01/2003EP1347757A2 Method for detoxifying a carbohydrate containing solution
10/01/2003EP1347756A2 Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart
10/01/2003EP1347755A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
10/01/2003EP1347754A2 Compositions for adhesion prevention
10/01/2003EP1347753A1 Topical composition and method for treating urinary stress incontinence
10/01/2003EP1347752A2 Anti-proliferative drugs
10/01/2003EP1347751A2 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists
10/01/2003EP1347750A1 Treatment of male sexual dysfunction
10/01/2003EP1347749A2 Transdermal therapeutic system comprising the active ingredient oxybutynin
10/01/2003EP1347748A2 Hydrostatic delivery system for controlled delivery of agent
10/01/2003EP1347747A2 Method for preparing submicron particle suspensions
10/01/2003EP1347745A2 Dietary composition containing conjugated linoleic acid and calcium for improved health
10/01/2003EP1347744A1 Solid dispersions of nitrate active principles
10/01/2003EP1347743A2 Composition for treatment of inflammatory disorders
10/01/2003EP1347742A1 Sustained release drug delivery devices with prefabricated permeable plugs
10/01/2003EP1237854B1 Comminuted form of (s)-2-ethoxy -3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid
10/01/2003EP1218339B1 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides
10/01/2003EP1206472B1 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
10/01/2003EP1204655B1 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
10/01/2003EP1202996B1 Titanium derived compounds, preparation and use thereof
10/01/2003EP1202954B1 Novel aminobenzophenones
10/01/2003EP1202724B1 Method for treating chronic pain using mek inhibitors
10/01/2003EP1200447B1 Oxazinocarbazoles for the treatment of cns diseases
10/01/2003EP1200435B1 Purine derivatives inhibitors of tyrosine protein kinase syk
10/01/2003EP1105393B1 Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
10/01/2003EP1100830B1 Heterominibodies
10/01/2003EP1097712B1 Steroid-containing cataplasms and process for producing the same
10/01/2003EP1097154B1 Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas
10/01/2003EP1097153B1 Novel triazolo[4,5-d]pyrimidine compounds
10/01/2003EP1094843B1 Targeted site specific drug delivery compositions and uses
10/01/2003EP1089996B1 Paroxetine methanesulfonate acetonitrile solvate 1:1
10/01/2003EP1084102B1 New 3-aryl propionic acid derivatives and analogs
10/01/2003EP1071665B1 Substituted indolinones having an inhibiting effect on kinases and cycline/cdk complexes
10/01/2003EP1056467B1 Method for the treatment of diseases or disorders of the inner ear
1 ... 5325 5326 5327 5328 5329 5330 5331 5332 5333 5334 5335 5336 5337 5338 5339 5340 5341 5342 5343 5344 5345 ... 7860